Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Actuate Therapeutics Inc.
City of Hope Medical Center
GlaxoSmithKline
Atavistik Bio, Inc
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
Duke University
AstraZeneca
Sapience Therapeutics
Poseida Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Loma Linda University
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Medstar Health Research Institute
Memorial Sloan Kettering Cancer Center
Swiss Cancer Institute
Seagen Inc.
Complement Theory Inc.
University of Southern California
UNICANCER
BicycleTx Limited
AstraZeneca
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Pfizer
Vanderbilt-Ingram Cancer Center
University of Colorado, Denver
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
University College, London
OncoC4, Inc.
Memorial Sloan Kettering Cancer Center
Klus Pharma Inc.
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Cybrexa Therapeutics
Carisma Therapeutics Inc
University of Toronto
Region Örebro County
Dana-Farber Cancer Institute
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc